UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effects of Safinamide on Pain in Fluctuating Parkinson's Disease Patients: A Post-Hoc Analysis

Journal of Parkinson's disease, 2017-01, Vol.7 (1), p.95-101

2017

Volltextzugriff (PDF)

Amyposomes, a nanotechnological chaperone with anti-amyloidogenic activity

Annals of medicine (Helsinki), 2023-12, Vol.55 (1), p.2205659-2205659

2023

Volltextzugriff (PDF)

High-Dose Acetylcysteine in Idiopathic Pulmonary Fibrosis

The New England journal of medicine, 2005-11, Vol.353 (21), p.2229-2242

2005

Volltextzugriff (PDF)

Long-Term Effects of Safinamide on Dyskinesia in Mid- to Late-Stage Parkinson’s Disease: A Post-Hoc Analysis

Journal of Parkinson's disease, 2015-09, Vol.5 (3), p.475-481

2015

Volltextzugriff (PDF)

Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial

The lancet respiratory medicine, 2014-03, Vol.2 (3), p.187-194

2014

Volltextzugriff (PDF)

Interaction of a Selective Cyclooxygenase-2 Inhibitor with Aspirin and NO-Releasing Aspirin in the Human Gastric Mucosa

Proceedings of the National Academy of Sciences - PNAS, 2003-09, Vol.100 (19), p.10937-10941

2003

Volltextzugriff (PDF)

Safinamide as Add-On Therapy to Levodopa in Mid- to Late-Stage Parkinson’s Disease Fluctuating Patients: Post hoc Analysesof Studies 016 and SETTLE

Journal of Parkinson's disease, 2016-03, Vol.6 (1), p.165-173

2016

Volltextzugriff (PDF)

Lung function in idiopathic pulmonary fibrosis--extended analyses of the IFIGENIA trial

Respiratory research, 2009-10, Vol.10 (1), p.101-101, Article 101

2009

Volltextzugriff (PDF)

Safinamide as Add-On Therapy to Levodopa in Mid- to Late-Stage Parkinson's Disease Fluctuating Patients: Post hoc Analyses of Studies 016 and SETTLE

Journal of Parkinson's disease, 2016-01, Vol.6 (1), p.165

2016

Volltextzugriff (PDF)

Safinamide Differentially Modulates In Vivo Glutamate and GABA Release in the Rat Hippocampus and Basal Ganglia

The Journal of pharmacology and experimental therapeutics, 2018-02, Vol.364 (2), p.198-206

2018

Volltextzugriff (PDF)

Long-Term Effects of Safinamide on Dyskinesia in Mid- to Late-Stage Parkinson's Disease: A Post-Hoc Analysis

Journal of Parkinson's disease, 2015-01, Vol.5 (3), p.475

2015

Volltextzugriff (PDF)

Post-hoc analysis of safinamide studies as add-on therapy to levodopa in mid- to late-stage fluctuating Parkinson’s disease patients

Parkinsonism & related disorders, 2016-01, Vol.22, p.e99-e99

2016

Volltextzugriff (PDF)

Favourable effect of safinamide on mood over 2-year treatment of fluctuating Parkinson’s disease patients

Parkinsonism & related disorders, 2016-01, Vol.22, p.e98-e99

2016

Volltextzugriff (PDF)

Efficacy, tolerability and safety of a new medical device, Monurelle Biogel® vaginal gel, in the treatment of vaginal dryness. A randomized clinical trial in women of reproductive age

European journal of obstetrics & gynecology and reproductive biology, 2016-08, Vol.203, p.82-88

2016

Volltextzugriff (PDF)

Safinamide and glutamate release: New insights

Parkinsonism & related disorders, 2016-01, Vol.22, p.e177-e177

2016

Volltextzugriff (PDF)

Safinamide differentially modulates glutamate release in the basal ganglia nuclei

Parkinsonism & related disorders, 2016-01, Vol.22, p.e176-e177

2016

Volltextzugriff (PDF)

Disposition and Metabolism of Safinamide, a Novel Drug for Parkinson's Disease, in Healthy Male Volunteers

Pharmacology, 2013-01, Vol.92 (3-4), p.207-216

2013

Volltextzugriff (PDF)

Population pharmacokinetic and pharmacodynamic analyses of safinamide in subjects with Parkinson's disease

Pharmacology research & perspectives, 2016-10, Vol.4 (5), p.e00251-n/a

2016

Volltextzugriff (PDF)

Pharmacokinetics of ITF 296 (Sinitrodil) a novel organic nitrate, in healthy volunteers

European journal of pharmaceutical sciences, 1999-02, Vol.7 (3), p.179-184

1999

Volltextzugriff (PDF)

Evaluation of the Effects of a New Intravaginal Gel, Containing Purified Bovine Colostrum, on Vaginal Blood Flow and Vaginal Atrophy in Ovariectomized Rat

Sexual medicine, 2013-12, Vol.1 (2), p.35-43

2013

Volltextzugriff (PDF)

TWICE DAILY N-ACETYLCYSTEINE 600 MG FOR EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (PANTHEON): A RANDOMISED, DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL

Pulʹmonologii͡a︡ (Moscow, Russia), 2014-01 (3), p.86-98

2014

Volltextzugriff (PDF)

Effect of HCT1026, a nitric oxide (NO) releasing derivative of flurbiprofen on gastrointestinal mucosa: a double blind placebo-controlled endoscopic study

Gastroenterology (New York, N.Y. 1943), 2003-04, Vol.124 (4), p.A511-A511

2003

Volltextzugriff (PDF)

Randomized trial of the effects of low-dose calcium-heparin in patients with peripheral arterial disease and claudication

The American journal of medicine, 1999-09, Vol.107 (3), p.234-239

1999

Volltextzugriff (PDF)

Randomized trial of the effects of low-dose calcium-heparin in patients with peripheral arterial disease and claudication11CAP Study Group: Enrico Feraco, MD, Orlando Grandinetti, MD (Cardiology Unit, INRCA, Cosenza), Giovanni Bellagamba, MD, Liliana Pennacchietti, MD (Cardiology Unit, INRCA, Fermo), Alvaro Vaccarella, MD, Gerardo Serra, MD (Cardiology Unit, INRCA, Casatenovo), Roberto Pedrinelli, MD, Elio Melillo, MD (1st Medical Clinic, University of Pisa), Gianfranco Boccoli, MD, Rosaria Gesu

The American journal of medicine, 1999-09, Vol.107 (3), p.234-239

1999

Volltextzugriff (PDF)

Celecoxib exacerbates gastrointestinal damage induced by aspirin but not by no-aspirin (NCX-4016): A randomised, parallel group, blind-observer endoscopic study. Evidence for a protective role of no in the gastrointestinal mucosa

Gastroenterology (New York, N.Y. 1943), 2003-04, Vol.124 (4), p.A93-A93

2003

Volltextzugriff (PDF)

1 – 25 von 95

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(80)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(67)
Life Sciences & Biomedicine
(61)
Humans
(30)
Male
(22)
Agriculture
(20)
Agriculture, Dairy & Animal Science
(20)
Adult
(17)
Female
(17)
Biological And Medical Sciences
(14)
Medical Sciences
(14)
Middle Aged
(14)
Sheep
(14)
Animals
(13)
Double-Blind Method
(12)
Veterinary Sciences
(12)
Aged
(11)
Cardiovascular System & Cardiology
(11)
Pharmacology. Drug Treatments
(11)
Genomes
(10)
Pharmacology & Pharmacy
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Effects of Safinamide on Pain in Fluctuating Parkinson's Disease Patients: A Post-Hoc Analysis

Amyposomes, a nanotechnological chaperone with anti-amyloidogenic activity

High-Dose Acetylcysteine in Idiopathic Pulmonary Fibrosis

Long-Term Effects of Safinamide on Dyskinesia in Mid- to Late-Stage Parkinson’s Disease: A Post-Hoc Analysis

Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial

Interaction of a Selective Cyclooxygenase-2 Inhibitor with Aspirin and NO-Releasing Aspirin in the Human Gastric Mucosa

Safinamide as Add-On Therapy to Levodopa in Mid- to Late-Stage Parkinson’s Disease Fluctuating Patients: Post hoc Analysesof Studies 016 and SETTLE

Lung function in idiopathic pulmonary fibrosis--extended analyses of the IFIGENIA trial

Safinamide as Add-On Therapy to Levodopa in Mid- to Late-Stage Parkinson's Disease Fluctuating Patients: Post hoc Analyses of Studies 016 and SETTLE

Safinamide Differentially Modulates In Vivo Glutamate and GABA Release in the Rat Hippocampus and Basal Ganglia

Long-Term Effects of Safinamide on Dyskinesia in Mid- to Late-Stage Parkinson's Disease: A Post-Hoc Analysis

Post-hoc analysis of safinamide studies as add-on therapy to levodopa in mid- to late-stage fluctuating Parkinson’s disease patients

Favourable effect of safinamide on mood over 2-year treatment of fluctuating Parkinson’s disease patients

Efficacy, tolerability and safety of a new medical device, Monurelle Biogel® vaginal gel, in the treatment of vaginal dryness. A randomized clinical trial in women of reproductive age

Safinamide and glutamate release: New insights

Safinamide differentially modulates glutamate release in the basal ganglia nuclei

Disposition and Metabolism of Safinamide, a Novel Drug for Parkinson's Disease, in Healthy Male Volunteers

Population pharmacokinetic and pharmacodynamic analyses of safinamide in subjects with Parkinson's disease

Pharmacokinetics of ITF 296 (Sinitrodil) a novel organic nitrate, in healthy volunteers

Evaluation of the Effects of a New Intravaginal Gel, Containing Purified Bovine Colostrum, on Vaginal Blood Flow and Vaginal Atrophy in Ovariectomized Rat

TWICE DAILY N-ACETYLCYSTEINE 600 MG FOR EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (PANTHEON): A RANDOMISED, DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL

Effect of HCT1026, a nitric oxide (NO) releasing derivative of flurbiprofen on gastrointestinal mucosa: a double blind placebo-controlled endoscopic study

Randomized trial of the effects of low-dose calcium-heparin in patients with peripheral arterial disease and claudication

Celecoxib exacerbates gastrointestinal damage induced by aspirin but not by no-aspirin (NCX-4016): A randomised, parallel group, blind-observer endoscopic study. Evidence for a protective role of no in the gastrointestinal mucosa

Suchergebnisse filtern